|Expense Ratio (net)||1.45%|
|Morningstar Risk Rating||High|
|Last Cap Gain||0.00|
|Inception Date||Jun 19, 2000|
|Average for Category||N/A|
The decline in biotech stocks is momentary and we expect the industry to bounce back in the coming days. So consider investing in these three biotech mutual funds.